RWA WEALTH PARTNERS, LLCRWA WEALTH PARTNERS, LLC

Institutional investor · Portfolio as of Q2 2026

Top Holdings645 positions

Checking export access…
Activity:
VUGVUG
ETF

Vanguard Index Funds MORNINGSTAR GROWTH ETF

13.5M$1.2B11.1%$37.89+140.96%
30 qtrssince 2019-Q1
Increased
100
VEAVEA
ETF

VANGUARD FTSE DEVELOPED MARKETS ETF

15.1M$1.1B10.3%$43.54+60.44%
30 qtrssince 2019-Q1
Increased
64
AGGAGG
ETF

ISHARES TR

9.2M$912.5M8.7%$94.87-0.25%
10 qtrssince 2024-Q1
Increased
66
VTVVTV
ETF

VANGUARD INDEX FDS

3.5M$762.7M7.3%$132.49+65.77%
30 qtrssince 2019-Q1
Increased
63
VWOVWO
ETF

Vanguard International Equity Index Funds FTSE EMR MKT ETF

4.7M$278.2M2.7%$41.36+42.90%
16 qtrssince 2022-Q3
Increased
55
VGSHVGSH
ETF

VANGUARD SHORT-TERM TREASURY ETF

4.5M$260M2.5%$56.43+2.03%
18 qtrssince 2022-Q1
Decreased
0

Apple Inc.

841,768$242.3M2.3%$168.60+101.91%
30 qtrssince 2019-Q1
Increased
56
MUBMUB
ETF

ISHARES NATIONAL MUNI BOND ETF

2.2M$242M2.3%$98.78+1.98%
30 qtrssince 2019-Q1
Decreased
0
CNEQCNEQ
ETF

ALGER CONCENTRATED EQUITY ETF

5.5M$228.5M2.2%$20.79+95.52%
4 qtrssince 2025-Q3
Increased
58
VTEBVTEB
ETF

VANGUARD TAX-EXEMPT BOND ETF

4.5M$226.4M2.2%$45.78+2.95%
30 qtrssince 2019-Q1
Increased
55

Microsoft Corp.

467,438$174.4M1.7%$321.46+62.57%
30 qtrssince 2019-Q1
Increased
53
VBKVBK
ETF

Vanguard Index Funds MORNINGSTAR SMALL-CAP GROWTH ETF

375,004$137.1M1.3%$216.02+57.67%
30 qtrssince 2019-Q1
Increased
48
IVVIVV
ETF

iShares Trust CORE S&P500 ETF

179,288$134.3M1.3%$437.45+77.68%
30 qtrssince 2019-Q1
Increased
49

JPMorgan Chase & Co.

401,962$131.6M1.3%$152.23+117.71%
30 qtrssince 2019-Q1
Increased
49
VBRVBR
ETF

VANGUARD MORNINGSTAR SMALL-CAP VALUE ETF

535,469$130.1M1.2%$164.58+42.13%
16 qtrssince 2022-Q3
Increased
49
SPYSPY
Unit

State Street Spdr S&p 500 Etf Trust TR UNIT

165,670$110.7M1.1%$452.50+71.03%
30 qtrssince 2019-Q1
Increased
53

Alphabet Inc.

303,547$108.5M1.0%$154.59+125.30%
30 qtrssince 2019-Q1
Decreased
0

Caterpillar Inc

94,652$100.8M1.0%$341.82+132.93%
30 qtrssince 2019-Q1
Decreased
0

Johnson & Johnson

387,249$98.3M0.9%$160.31+59.99%
30 qtrssince 2019-Q1
Increased
50

Eli Lilly & Co.

76,026$91.2M0.9%$667.12+75.32%
19 qtrssince 2021-Q4
Increased
48
$10.4B
AUM
645
Positions
Q2 2026
Filing
HI score · 5.0/5
Quarterly 13F Value Change
-2%Q1'25$7.9B+1%Q2'25$8B+10%Q3'25$8.8B+4%Q4'25$9.1B-0%Q1'26$9.1B+14%Q2'26$10.4B
Activity profile
$ moved · Q2'26
New4%Increased72%Decreased19%Exited4%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.8 years
<1Q6%1-4Q9%1-2Y12%2Y+73%

RWA WEALTH PARTNERS, LLC manages $10.4B across 645 positions as of Q2 2026. Top holdings: VUG (11.1%), VEA (10.3%), AGG (8.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 5/5.0.

Q2 2026 Summary

Active quarter - 56 new positions, 29 exits, 308 increased. Top move: VUG (INCREASED, conviction 100). Portfolio: $10.4B across 645 positions.

Top holdings by portfolio weight

Total AUM$10B
VUG11.11%
VEA10.30%
AGG8.74%
VTV7.30%
VWO2.66%
VGSH2.49%
AAPL2.32%
MUB2.32%
CNEQ2.19%
VTEB2.17%
Other1.67%

Portfolio allocation by GICS sector

Sectors11
Unknown68.17%
Technology10.20%
Financial Services4.72%
Healthcare4.27%
Industrials3.40%
Consumer Cyclical2.71%
Communication Services2.13%
Consumer Defensive1.91%
Energy1.19%
Basic Materials0.64%
Other0.65%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(5.0 / 5.0)
Holdings P&L66
Conviction42
Concentration77
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
RSPRSPINVESCO EXCHANGE TRADED FD T
Q4 2024 → Q2 2026+45,548 shares+$9.9M
7Q
NEARNEARISHARES U S ETF TR
Q4 2024 → Q2 2026+736 shares+$32,160
7Q
IBDVIBDVISHARES TR
Q4 2024 → Q2 2026+184,815 shares+$3.9M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used